These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 20130674)

  • 1. Applying Hsp104 to protein-misfolding disorders.
    Vashist S; Cushman M; Shorter J
    Biochem Cell Biol; 2010 Feb; 88(1):1-13. PubMed ID: 20130674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of hsp104, a protein disaggregase.
    Sweeny EA; DeSantis ME; Shorter J
    J Vis Exp; 2011 Sep; (55):. PubMed ID: 21989490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Operational plasticity enables hsp104 to disaggregate diverse amyloid and nonamyloid clients.
    DeSantis ME; Leung EH; Sweeny EA; Jackrel ME; Cushman-Nick M; Neuhaus-Follini A; Vashist S; Sochor MA; Knight MN; Shorter J
    Cell; 2012 Nov; 151(4):778-793. PubMed ID: 23141537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolating potentiated Hsp104 variants using yeast proteinopathy models.
    Jackrel ME; Tariq A; Yee K; Weitzman R; Shorter J
    J Vis Exp; 2014 Nov; (93):e52089. PubMed ID: 25407485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the Hsp104 middle domain activity is critical for yeast prion propagation.
    Dulle JE; Stein KC; True HL
    PLoS One; 2014; 9(1):e87521. PubMed ID: 24466354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiated Hsp104 variants antagonize diverse proteotoxic misfolding events.
    Jackrel ME; DeSantis ME; Martinez BA; Castellano LM; Stewart RM; Caldwell KA; Caldwell GA; Shorter J
    Cell; 2014 Jan; 156(1-2):170-82. PubMed ID: 24439375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective Hsp70-Dependent Docking of Hsp104 to Protein Aggregates Protects the Cell from the Toxicity of the Disaggregase.
    Chamera T; Kłosowska A; Janta A; Wyszkowski H; Obuchowski I; Gumowski K; Liberek K
    J Mol Biol; 2019 May; 431(11):2180-2196. PubMed ID: 31026451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of endogenous Hsp104 chaperone in yeast models of sporadic and familial Parkinson's disease.
    Gade VR; Kardani J; Roy I
    Int J Biochem Cell Biol; 2014 Oct; 55():87-92. PubMed ID: 25161148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coordinated Hsp110 and Hsp104 Activities Power Protein Disaggregation in Saccharomyces cerevisiae.
    Kaimal JM; Kandasamy G; Gasser F; Andréasson C
    Mol Cell Biol; 2017 Jun; 37(11):. PubMed ID: 28289075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mammalian disaggregase machinery: Hsp110 synergizes with Hsp70 and Hsp40 to catalyze protein disaggregation and reactivation in a cell-free system.
    Shorter J
    PLoS One; 2011; 6(10):e26319. PubMed ID: 22022600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applying chaperones to protein-misfolding disorders: molecular chaperones against α-synuclein in Parkinson's disease.
    Chaari A; Hoarau-Véchot J; Ladjimi M
    Int J Biol Macromol; 2013 Sep; 60():196-205. PubMed ID: 23748003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering enhanced protein disaggregases for neurodegenerative disease.
    Jackrel ME; Shorter J
    Prion; 2015; 9(2):90-109. PubMed ID: 25738979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metazoan protein disaggregase and amyloid depolymerase system: Hsp110, Hsp70, Hsp40, and small heat shock proteins.
    Torrente MP; Shorter J
    Prion; 2013; 7(6):457-63. PubMed ID: 24401655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial and Yeast AAA+ Disaggregases ClpB and Hsp104 Operate through Conserved Mechanism Involving Cooperation with Hsp70.
    Kummer E; Szlachcic A; Franke KB; Ungelenk S; Bukau B; Mogk A
    J Mol Biol; 2016 Oct; 428(21):4378-4391. PubMed ID: 27616763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spiraling in Control: Structures and Mechanisms of the Hsp104 Disaggregase.
    Shorter J; Southworth DR
    Cold Spring Harb Perspect Biol; 2019 Aug; 11(8):. PubMed ID: 30745294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsp104 N-terminal domain interaction with substrates plays a regulatory role in protein disaggregation.
    Harari A; Zoltsman G; Levin T; Rosenzweig R
    FEBS J; 2022 Sep; 289(17):5359-5377. PubMed ID: 35305079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hsp104: a weapon to combat diverse neurodegenerative disorders.
    Shorter J
    Neurosignals; 2008; 16(1):63-74. PubMed ID: 18097161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering therapeutic protein disaggregases.
    Shorter J
    Mol Biol Cell; 2016 May; 27(10):1556-60. PubMed ID: 27255695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small heat shock proteins potentiate amyloid dissolution by protein disaggregases from yeast and humans.
    Duennwald ML; Echeverria A; Shorter J
    PLoS Biol; 2012; 10(6):e1001346. PubMed ID: 22723742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine diphosphate restricts the protein remodeling activity of the Hsp104 chaperone to Hsp70 assisted disaggregation.
    Kłosowska A; Chamera T; Liberek K
    Elife; 2016 May; 5():. PubMed ID: 27223323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.